SELLAS Life Sciences Group, Inc. (SLS)

4.045 +0.20 (+5.34%) USD  |  NASDAQ  |  Jan 16, 14:57
More

SELLAS Life Sciences Group EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade